Financial Snapshot

Revenue
$76.63M
TTM
Gross Margin
99.52%
TTM
Net Earnings
-$185.5M
TTM
Current Assets
Q4 2024
Current Liabilities
Q4 2024
Current Ratio
20.58%
Q4 2024
Total Assets
Q4 2024
Total Liabilities
$252.6M
Q4 2024
Book Value
-$26.34M
Q4 2024
Cash
Q4 2024
P/E
-0.4339
Nov 29, 2024 EST
Free Cash Flow
-$130.2M
TTM

Revenues

Revenues

Revenue YoY Change

Revenues

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Revenue $103.5M $156.3M $98.02M $295.7M $88.17M $150.0M $36.78M $168.1K $147.5K $24.82M $6.977M $3.045M $15.96M $2.756M $3.360M $3.300M $2.700M $5.600M $700.0K $600.0K $700.0K $1.000M $3.400M $4.600M $400.0K $600.0K $0.00 $0.00
YoY Change -33.81% 59.47% -66.85% 235.34% -41.24% 307.92% 21788.59% 13.97% -99.41% 255.67% 129.13% -80.92% 479.17% -17.97% 1.81% 22.22% -51.79% 700.0% 16.67% -14.29% -30.0% -70.59% -26.09% 1050.0% -33.33%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Revenue $103.5M $156.3M $98.02M $295.7M $88.17M $150.0M $36.78M $168.1K $147.5K $24.82M $6.977M $3.045M $15.96M $2.756M $3.360M $3.300M $2.700M $5.600M $700.0K $600.0K $700.0K $1.000M $3.400M $4.600M $400.0K $600.0K $0.00 $0.00
Cost Of Revenue $486.0K $3.111M $10.57M $3.470M $2.349M $0.00 $0.00 $536.1K $672.0K $0.00 $122.9K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.300M $1.100M $400.0K $0.00 $0.00
Gross Profit $103.0M $153.2M $87.46M $292.2M $85.82M $24.80M $6.977M $2.509M $15.29M $2.756M $3.237M $3.300M $2.700M $700.0K $600.0K $700.0K $1.000M $2.100M $3.500M $100.0K $600.0K $0.00
Gross Profit Margin 99.53% 98.01% 89.22% 98.83% 97.34% 99.93% 100.0% 82.39% 95.79% 100.0% 96.34% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 61.76% 76.09% 25.0% 100.0%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Selling, General & Admin $78.74M $81.01M $76.36M $59.20M $46.00M $37.30M $33.70M $33.10M $28.40M $21.20M $14.50M $11.50M $10.80M $12.10M $14.10M $19.80M $17.00M $21.30M $25.90M $25.80M $21.70M $19.50M $13.80M $9.200M $7.500M $3.700M $1.500M
YoY Change -2.8% 6.09% 28.98% 28.7% 23.32% 10.68% 1.81% 16.55% 33.96% 46.21% 26.09% 6.48% -10.74% -14.18% -28.79% 16.47% -20.19% -17.76% 0.39% 18.89% 11.28% 41.3% 50.0% 22.67% 102.7% 146.67% -16.67%
% of Gross Profit 51.4% 92.63% 26.13% 68.98% 114.52% 303.84% 577.9% 75.22% 391.9% 373.84% 427.27% 733.33% 3042.86% 4316.67% 3685.71% 2170.0% 928.57% 394.29% 9200.0% 1250.0%
Research & Development $155.5M $234.6M $186.7M $178.6M $142.6M $168.3M $124.6M $116.1M $94.97M $70.44M $22.35M $13.01M $10.56M $11.02M $12.88M $16.90M $20.70M $21.80M $28.60M $47.10M $41.70M $46.30M $40.00M $31.40M $17.60M $12.00M $5.900M $2.600M
YoY Change -33.7% 25.65% 4.53% 25.24% -15.28% 35.1% 7.3% 22.27% 34.82% 215.2% 71.85% 23.11% -4.16% -14.41% -23.8% -18.36% -5.05% -23.78% -39.28% 12.95% -9.94% 15.75% 27.39% 78.41% 46.67% 103.39% 126.92% 30.0%
% of Gross Profit 151.03% 153.11% 213.47% 61.13% 166.18% 284.05% 320.31% 518.33% 69.1% 399.97% 397.87% 512.12% 766.67% 4085.71% 7850.0% 5957.14% 4630.0% 1904.76% 897.14% 17600.0% 2000.0%
Depreciation & Amortization $12.80M $11.90M $4.700M $4.600M $5.100M $4.800M $4.300M $3.800M $2.700M $1.400M $1.100M $586.0K $1.600M $2.200M $2.600M $4.110M $4.630M $5.380M $5.660M $5.590M $4.810M $6.490M $5.470M $4.150M $1.680M $1.010M $360.0K $200.0K
YoY Change 7.56% 153.19% 2.17% -9.8% 6.25% 11.63% 13.16% 40.74% 92.86% 27.27% 87.71% -63.38% -27.27% -15.38% -36.74% -11.23% -13.94% -4.95% 1.25% 16.22% -25.89% 18.65% 31.81% 147.02% 66.34% 180.56% 80.0% 100.0%
% of Gross Profit 12.43% 7.77% 5.37% 1.57% 5.94% 5.65% 15.77% 23.36% 10.47% 79.83% 80.33% 124.55% 171.48% 808.57% 931.67% 687.14% 649.0% 260.48% 118.57% 1680.0% 168.33%
Operating Expenses $155.5M $234.6M $186.7M $178.6M $142.6M $168.3M $124.6M $116.1M $94.97M $70.44M $22.35M $13.01M $10.56M $11.02M $12.88M $31.00M $40.50M $38.80M $49.90M $72.90M $67.50M $67.90M $59.50M $45.10M $26.70M $19.40M $9.600M $4.300M
YoY Change -33.7% 25.65% 4.53% 25.24% -15.28% 35.1% 7.3% 22.27% 34.82% 215.2% 71.85% 23.11% -4.16% -14.41% -58.46% -23.46% 4.38% -22.24% -31.55% 8.0% -0.59% 14.12% 31.93% 68.91% 37.63% 102.08% 123.26% 10.26%
Operating Profit -$120.5M -$159.5M -$179.4M $113.6M -$117.2M -$70.14M -$123.8M -$103.8M -$107.5M -$80.70M -$43.32M -$24.98M -$6.741M -$19.09M -$21.75M -$27.70M -$37.80M -$49.20M -$72.30M -$66.80M -$66.90M -$57.40M -$41.60M -$26.60M -$18.80M -$9.600M
YoY Change -24.49% -11.08% -257.96% -196.89% 67.15% -43.36% 19.29% -3.42% 33.18% 86.29% 73.42% 270.59% -64.68% -12.25% -21.47% -26.72% -31.95% 8.23% -0.15% 16.55% 37.98% 56.39% 41.49% 95.83%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Interest Expense -$117.6M -$97.93M -$61.86M -$77.20M -$61.08M -$41.45M -$25.27M -$18.87M -$17.32M -$6.599M $1.262M $2.420M $4.695M $4.210M $4.871M -$5.200M -$5.300M -$4.700M -$1.400M -$200.0K $900.0K $900.0K $1.200M $2.700M $5.800M $700.0K $700.0K $500.0K
YoY Change 20.12% 58.29% -19.87% 26.4% 47.35% 64.01% 33.94% 8.97% 162.4% -623.06% -47.86% -48.46% 11.51% -13.58% -193.68% -1.89% 12.77% 235.71% 600.0% -122.22% 0.0% -25.0% -55.56% -53.45% 728.57% 0.0% 40.0% 66.67%
% of Operating Profit -67.97%
Other Income/Expense, Net $5.830M $37.00K $12.57M $5.051M -$1.858M $28.00K -$2.183M $1.977M -$2.202M -$5.968M $2.096M -$2.673M $110.5K $1.941K $4.680M $2.600M $12.40M $0.00 $100.0K $0.00 $0.00 $0.00 $300.0K $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 15656.76% -99.71% 148.88% -371.85% -6735.71% -101.28% -210.4% -189.79% -63.1% -384.7% -178.43% -2519.38% 5591.55% -99.96% 80.0% -79.03% -100.0% -100.0% -100.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

No data

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Pretax Income -$257.4M -$230.7M -$28.72M -$182.9M -$111.6M -$162.0M -$120.7M -$127.0M -$93.27M -$42.49M -$30.07M -$11.30M -$23.30M -$21.90M -$30.30M -$30.80M -$37.90M -$51.90M -$74.10M -$68.80M -$66.00M -$55.90M -$73.50M -$46.70M -$18.10M -$8.900M -$3.800M
YoY Change 11.61% 703.01% -84.3% 63.89% -31.11% 34.22% -4.96% 36.17% 119.53% 41.28% 166.13% -51.5% 6.39% -27.72% -1.62% -18.73% -26.97% -29.96% 7.7% 4.24% 18.07% -23.95% 57.39% 158.01% 103.37% 134.21% 15.15%
Income Tax $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -$5.387M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$232.3M -$257.4M -$230.7M -$28.72M -$182.9M -$111.6M -$162.0M -$120.7M -$127.0M -$87.88M -$42.49M -$30.07M -$11.32M -$23.28M -$21.91M -$30.30M -$30.80M -$37.90M -$51.90M -$74.10M -$56.20M -$65.90M -$55.90M -$73.50M -$46.70M -$18.10M -$8.900M -$3.800M
YoY Change -9.78% 11.61% 703.01% -84.29% 63.94% -31.15% 34.26% -4.96% 44.51% 106.85% 41.28% 165.55% -51.35% 6.25% -27.7% -1.62% -18.73% -26.97% -29.96% 31.85% -14.72% 17.89% -23.95% 57.39% 158.01% 103.37% 134.21% 15.15%
Net Earnings / Revenue -224.5% -164.69% -235.31% -9.72% -207.43% -74.35% -440.53% -71818.67% -86124.11% -354.12% -608.91% -987.54% -70.95% -844.63% -652.05% -918.18% -1140.74% -676.79% -7414.29% -12350.0% -8028.57% -6590.0% -1644.12% -1597.83% -11675.0% -3016.67%
Basic Earnings Per Share -$10.59 -$0.69 -$0.78 -$0.11 -$1.05
Diluted Earnings Per Share -$10.59 -$0.69 -$0.78 -$104.5K -$1.049M -$797.8K -$1.441M -$1.227M -$1.458M -$1.124M -$710.7K -$1.010M -$478.8K -$1.171M -$1.360M -$2.295M -$2.933M -$4.859M -$6.829M -$9.750M -$7.595M -$10.14M -$10.16M -$15.64M -$11.39M -$6.033M -$3.296M -$1.462M

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

No data

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Cash & Short-Term Investments $76.11M $193.4M $306.9M $99.90M $61.80M $53.10M $60.20M $76.40M $171.7M $40.20M $27.40M $21.50M $10.70M $19.80M $30.10M $34.50M $18.70M $40.10M $61.70M $86.90M $88.00M $58.70M $60.90M $99.10M $46.40M $22.20M
YoY Change -60.64% -37.0% 207.23% 61.65% 16.38% -11.79% -21.2% -55.5% 327.11% 46.72% 27.44% 100.93% -45.96% -34.22% -12.75% 84.49% -53.37% -35.01% -29.0% -1.25% 49.91% -3.61% -38.55% 113.58% 109.01%
Cash & Equivalents $76.11M $178.7M $291.9M $99.90M $61.80M $53.10M $60.20M $71.40M $136.7M $25.70M $27.40M $21.50M $10.70M $19.80M $20.10M $24.50M $14.50M $24.20M $33.20M $16.00M $24.40M $33.10M $60.90M $96.10M $46.40M $22.20M
Short-Term Investments $0.00 $14.68M $14.99M $0.00 $5.000M $35.00M $14.50M $0.00 $10.00M $10.00M $4.200M $15.90M $28.50M $70.90M $63.60M $25.60M $0.00 $3.000M $0.00
Other Short-Term Assets $10.47M $17.02M $23.53M $12.70M $8.400M $20.80M $12.20M $3.400M $2.600M $2.300M $900.0K $500.0K $1.200M $1.000M $1.200M $800.0K $1.200M $1.600M $5.000M $5.400M $3.600M $2.600M $1.200M $1.200M $700.0K $200.0K
YoY Change -38.49% -27.66% 85.3% 51.19% -59.62% 70.49% 258.82% 30.77% 13.04% 155.56% 80.0% -58.33% 20.0% -16.67% 50.0% -33.33% -25.0% -68.0% -7.41% 50.0% 38.46% 116.67% 0.0% 71.43% 250.0%
Inventory $0.00 $100.0K $100.0K $100.0K $100.0K $100.0K $0.00 $0.00 $0.00 $0.00 $300.0K $200.0K $500.0K $400.0K $300.0K $200.0K $200.0K $1.000M $1.400M $700.0K $0.00
Prepaid Expenses
Receivables $25.84M $2.741M $1.518M $1.200M $16.30M $900.0K $1.100M $11.40M $9.800M $0.00 $0.00 $600.0K $0.00 $0.00 $300.0K $200.0K $0.00 $100.0K $0.00 $1.100M $500.0K $500.0K $600.0K
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $112.4M $213.1M $332.0M $113.8M $86.50M $74.80M $73.60M $91.30M $184.1M $42.70M $28.20M $22.60M $12.00M $20.90M $31.50M $35.50M $20.80M $42.30M $67.00M $92.60M $91.80M $63.40M $64.00M $101.6M $47.70M $22.40M
YoY Change -47.25% -35.8% 191.72% 31.56% 15.64% 1.63% -19.39% -50.41% 331.15% 51.42% 24.78% 88.33% -42.58% -33.65% -11.27% 70.67% -50.83% -36.87% -27.65% 0.87% 44.79% -0.94% -37.01% 113.0% 112.95%
Property, Plant & Equipment $163.0M $164.3M $91.08M $60.30M $33.70M $25.10M $26.20M $25.60M $15.30M $6.000M $2.800M $2.600M $4.100M $6.200M $8.900M $11.50M $14.60M $18.60M $23.40M $25.00M $24.80M $11.40M $13.90M $14.60M $8.000M $4.100M
YoY Change -0.77% 80.37% 51.05% 78.93% 34.26% -4.2% 2.34% 67.32% 155.0% 114.29% 7.69% -36.59% -33.87% -30.34% -22.61% -21.23% -21.51% -20.51% -6.4% 0.81% 117.54% -17.99% -4.79% 82.5% 95.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $9.336M $4.453M $9.537M $4.100M $1.400M $1.200M $1.200M $1.300M $1.300M $1.200M $1.300M $1.300M $1.100M $1.300M $1.600M $4.800M $3.000M $4.800M $5.500M $6.000M $12.40M $2.100M $2.400M $2.100M $300.0K $100.0K
YoY Change 109.66% -53.31% 132.61% 192.86% 16.67% 0.0% -7.69% 0.0% 8.33% -7.69% 0.0% 18.18% -15.38% -18.75% -66.67% 60.0% -37.5% -12.73% -8.33% -51.61% 490.48% -12.5% 14.29% 600.0% 200.0%
Total Long-Term Assets $201.5M $200.4M $134.0M $100.7M $68.80M $61.60M $64.80M $65.70M $58.10M $31.80M $6.600M $6.500M $7.800M $10.00M $14.40M $21.30M $23.70M $30.70M $37.20M $40.50M $48.30M $25.70M $29.50M $26.40M $8.300M $4.200M
YoY Change 0.53% 49.6% 33.05% 46.37% 11.69% -4.94% -1.37% 13.08% 82.7% 381.82% 1.54% -16.67% -22.0% -30.56% -32.39% -10.13% -22.8% -17.47% -8.15% -16.15% 87.94% -12.88% 11.74% 218.07% 97.62%
Total Assets $313.9M $413.6M $466.0M $214.5M $155.3M $136.4M $138.4M $157.0M $242.2M $74.50M $34.80M $29.10M $19.80M $30.90M $45.90M $56.80M $44.50M $73.00M $104.2M $133.1M $140.1M $89.10M $93.50M $128.0M $56.00M $26.60M
YoY Change
Accounts Payable $61.45M $40.94M $30.49M $17.00M $13.60M $13.60M $8.100M $5.400M $4.500M $1.700M $800.0K $600.0K $800.0K $700.0K $900.0K $500.0K $700.0K $1.100M $2.600M $2.900M $3.200M $1.400M $2.900M $2.300M $400.0K $2.000M
YoY Change 50.09% 34.29% 79.33% 25.0% 0.0% 67.9% 50.0% 20.0% 164.71% 112.5% 33.33% -25.0% 14.29% -22.22% 80.0% -28.57% -36.36% -57.69% -10.34% -9.38% 128.57% -51.72% 26.09% 475.0% -80.0%
Accrued Expenses $47.87M $40.20M $44.72M $31.00M $32.70M $24.60M $21.60M $27.90M $14.20M $5.500M $4.200M $2.200M $1.700M $2.700M $2.600M $4.600M $5.800M $7.600M $12.30M $10.90M $11.30M $8.000M $7.400M $4.000M $900.0K $0.00
YoY Change 19.07% -10.1% 44.25% -5.2% 32.93% 13.89% -22.58% 96.48% 158.18% 30.95% 90.91% 29.41% -37.04% 3.85% -43.48% -20.69% -23.68% -38.21% 12.84% -3.54% 41.25% 8.11% 85.0% 344.44%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $10.60M $8.527M $1.063M $1.600M $800.0K $100.0K $20.60M $100.0K $100.0K $1.300M $3.500M $200.0K $200.0K $100.0K $100.0K $100.0K $100.0K $100.0K $4.100M $5.400M $5.600M $500.0K $5.900M $2.300M $800.0K $200.0K
YoY Change 24.35% 702.16% -33.56% 100.0% 700.0% -99.51% 20500.0% 0.0% -92.31% -62.86% 1650.0% 0.0% 100.0% 0.0% 0.0% 0.0% 0.0% -97.56% -24.07% -3.57% 1020.0% -91.53% 156.52% 187.5% 300.0%
Total Short-Term Liabilities $255.9M $189.0M $156.9M $129.9M $122.2M $68.10M $56.40M $40.90M $28.90M $9.200M $10.30M $4.800M $4.800M $5.400M $5.400M $7.000M $8.400M $9.100M $19.10M $19.20M $22.10M $10.00M $16.20M $8.600M $2.200M $2.300M
YoY Change 35.43% 20.4% 20.82% 6.3% 79.44% 20.74% 37.9% 41.52% 214.13% -10.68% 114.58% 0.0% -11.11% 0.0% -22.86% -16.67% -7.69% -52.36% -0.52% -13.12% 121.0% -38.27% 88.37% 290.91% -4.35%
Long-Term Debt $17.49M $24.85M $13.14M $18.90M $13.40M $13.20M $142.4M $130.5M $114.3M $4.800M $5.300M $35.70M $32.70M $34.10M $49.50M $64.10M $77.40M $75.30M $50.00M $4.500M $10.20M $0.00 $200.0K $2.600M $2.200M $700.0K
YoY Change -29.64% 89.13% -30.47% 41.04% 1.52% -90.73% 9.12% 14.17% 2281.25% -9.43% -85.15% 9.17% -4.11% -31.11% -22.78% -17.18% 2.79% 50.6% 1011.11% -55.88% -100.0% -92.31% 18.18% 214.29%
Other Long-Term Liabilities $188.9M $254.7M $248.0M $250.3M $224.2M $189.8M $15.40M $24.70M $28.20M $37.50M $23.70M $6.200M $3.200M $6.100M $8.000M $6.000M $5.800M $5.900M $3.100M $2.900M $2.500M $1.300M $1.200M $0.00 $0.00
YoY Change -25.82% 2.7% -0.93% 11.64% 18.12% 1132.47% -37.65% -12.41% -24.8% 58.23% 282.26% 93.75% -47.54% -23.75% 33.33% 3.45% -1.69% 90.32% 6.9% 16.0% 92.31% 8.33%
Total Long-Term Liabilities $206.4M $279.5M $261.1M $269.2M $237.6M $203.0M $157.8M $155.2M $142.5M $42.30M $29.00M $41.90M $35.90M $40.20M $57.50M $70.10M $83.20M $81.20M $53.10M $7.400M $12.70M $1.300M $1.400M $2.600M $2.200M $700.0K
YoY Change -26.16% 7.05% -3.01% 13.3% 17.04% 28.64% 1.68% 8.91% 236.88% 45.86% -30.79% 16.71% -10.7% -30.09% -17.97% -15.75% 2.46% 52.92% 617.57% -41.73% 876.92% -7.14% -46.15% 18.18% 214.29%
Total Liabilities $474.2M $474.8M $431.5M $391.3M $353.8M $269.0M $214.2M $196.1M $171.5M $51.50M $39.30M $52.30M $46.20M $45.60M $62.80M $77.20M $91.60M $90.30M $72.30M $26.60M $34.80M $11.30M $17.60M $11.30M $4.300M $3.000M
YoY Change -0.12% 10.04% 10.28% 10.6% 31.52% 25.58% 9.23% 14.34% 233.01% 31.04% -24.86% 13.2% 1.32% -27.39% -18.65% -15.72% 1.44% 24.9% 171.8% -23.56% 207.96% -35.8% 55.75% 162.79% 43.33%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

No data

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Basic Shares Outstanding 21.47M 357.9K 281.7K 228.9K 172.5K
Diluted Shares Outstanding 21.47M 357.9K 281.7K 228.9K 172.5K
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Dividends

No data

Stock Price

Market Cap: $80.464 Million

About AGENUS INC

Agenus Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Lexington, Massachusetts and currently employs 389 full-time employees. The company went IPO on 2000-02-04. Agenus Inc. is an immuno-oncology (I-O) company targeting cancer and infectious diseases with a pipeline of immunological agents. The company is specialized in developing therapies to activate the body's immune system against cancer and infections. Its pipeline includes immune-modulatory antibodies, adoptive cell therapies (via MiNK Therapeutics, Inc.), and vaccine adjuvants (via SaponiQx, Inc.). Its primary focus is I-O, and its diverse pipeline is supported by its in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. Its most advanced antibody candidates are botensilimab (a multifunctional immune cell activator and human Fc-enhanced cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody (AGEN1811)) and balstilimab (a programmed death receptor-1 (PD-1) blocking antibody). Its pipeline includes several classes of immunotherapies: checkpoint inhibitors, immune activators, and tumor microenvironment conditioning agents.

Industry: Biological Products, (No Diagnostic Substances) Peers: Adicet Bio, Inc. Altimmune, Inc. Century Therapeutics, Inc. Cullinan Therapeutics, Inc. HilleVax, Inc. Inhibrx, Inc. Kezar Life Sciences, Inc. Nurix Therapeutics, Inc. Vera Therapeutics, Inc.